Pictet Asset Management Sa Amicus Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 9,442,588 shares of FOLD stock, worth $88.9 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
9,442,588
Previous 9,984,901
5.43%
Holding current value
$88.9 Million
Previous $111 Million
7.1%
% of portfolio
0.14%
Previous 0.14%
Shares
8 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$271 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$264 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$229 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$226 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$218 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.64B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...